Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E Cigarettes
Clinical trial NCT07392125 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07392125
- Sponsor
- Achieve Life Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-15
- Primary completion
- 2026-11-15
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.